Testing effectiveness (Phase 2)Study completedNCT05080790
What this trial is testing
Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma
Who this might be right for
Leiomyosarcoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 7